← Leaderboards
Anahid Jewett
University Of California Los Angeles
$958,244
Attributed
$958,244
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$958,244 · 2
By mechanism
R01$958,244 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Karen Reue$30,995,314
- Ichiro Nishimura$3,632,930
- Sanjiv S Gambhir$44,452,033
- Mo Kwan Kang$3,420,661
- Reuben Han-Kyu Kim$4,789,352
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisBiological Signal TransductionCytokine ReceptorsCarcinomaCell Cell InteractionCytotoxicityCytotoxic T LymphocyteDna Binding ProteinHuman TissueImmunosuppressionInterferon GammaJun KinaseNatural Killer CellsNeoplasm /Cancer ImmunologyNeoplastic CellNeoplastic ProcessNuclear Factor Kappa BetaOral Pharyngeal NeoplasmProtein Tyrosine KinaseReceptor ExpressionTransforming Growth FactorsTumor Necrosis Factor AlphaPolymerase Chain ReactionImmune Tolerance /Unresponsiveness
Grant awards (6)
Inactivation of Cytotoxic Effectors in Oral Carcinomas$216,992
R01 · FY2003 · DE
Inactivation of Cytotoxic Effectors in Oral Carcinomas$39,770
R01 · FY2003 · DE
Inactivation of Cytotoxic Effectors in Oral Carcinomas$26,068
R01 · FY2003 · DE
CHEMICAL RELEASE &IMMUNE SENSITIZATION BY DENTAL RESINS$240,658
R01 · FY2002 · DE
Inactivation of Cytotoxic Effectors in Oral Carcinomas$217,052
R01 · FY2002 · DE
Inactivation of Cytotoxic Effectors in Oral Carcinomas$217,704
R01 · FY2001 · DE